Erik Sætre

772 total citations
18 papers, 547 citations indexed

About

Erik Sætre is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Genetics. According to data from OpenAlex, Erik Sætre has authored 18 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pediatrics, Perinatology and Child Health, 18 papers in Psychiatry and Mental health and 4 papers in Genetics. Recurrent topics in Erik Sætre's work include Epilepsy research and treatment (18 papers), Pharmacological Effects and Toxicity Studies (18 papers) and Hemoglobinopathies and Related Disorders (4 papers). Erik Sætre is often cited by papers focused on Epilepsy research and treatment (18 papers), Pharmacological Effects and Toxicity Studies (18 papers) and Hemoglobinopathies and Related Disorders (4 papers). Erik Sætre collaborates with scholars based in Norway, Finland and United States. Erik Sætre's co-authors include Leif Gjerstad, Jouko Isojärvi, Emilio Perucca, Erik Taubøll, Line Sveberg Røste, Michael Abdelnoor, Tore Mørland, Svein I. Johannessen, Lars Mørkrid and Trine B. Haugen and has published in prestigious journals such as Epilepsia, European Journal of Neurology and Epilepsy Research.

In The Last Decade

Erik Sætre

15 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Sætre Norway 12 447 424 102 75 56 18 547
Ricardo Ayala United States 6 438 1.0× 410 1.0× 163 1.6× 42 0.6× 17 0.3× 20 549
Alain Vuong United States 17 564 1.3× 522 1.2× 101 1.0× 31 0.4× 59 1.1× 25 710
Rossella Manco Italy 11 258 0.6× 243 0.6× 69 0.7× 59 0.8× 26 0.5× 19 485
Giulia Loiacono Italy 11 215 0.5× 191 0.5× 63 0.6× 9 0.1× 13 0.2× 18 332
J Blacklaw United Kingdom 11 385 0.9× 344 0.8× 110 1.1× 44 0.6× 25 0.4× 11 420
S. Koch Germany 12 598 1.3× 972 2.3× 52 0.5× 631 8.4× 33 0.6× 27 1.1k
R E Appleton United Kingdom 10 322 0.7× 290 0.7× 82 0.8× 33 0.4× 33 0.6× 13 405
J. Eric Piña-Garza United States 16 722 1.6× 597 1.4× 203 2.0× 17 0.2× 29 0.5× 36 899
Nikola Vojvodić Serbia 11 190 0.4× 143 0.3× 98 1.0× 31 0.4× 21 0.4× 46 443
Arton Baftiu Norway 13 354 0.8× 339 0.8× 57 0.6× 37 0.5× 16 0.3× 18 426

Countries citing papers authored by Erik Sætre

Since Specialization
Citations

This map shows the geographic impact of Erik Sætre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Sætre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Sætre more than expected).

Fields of papers citing papers by Erik Sætre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Sætre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Sætre. The network helps show where Erik Sætre may publish in the future.

Co-authorship network of co-authors of Erik Sætre

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Sætre. A scholar is included among the top collaborators of Erik Sætre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Sætre. Erik Sætre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Landmark, Cecilie Johannessen, et al.. (2025). A precision approach to therapeutic drug monitoring of valproate to evaluate markers of toxicity. Epilepsia. 66(10). 3741–3756.
2.
Landmark, Cecilie Johannessen, Erik Sætre, Torleiv Svendsen, et al.. (2025). Pharmacokinetic variability and use of therapeutic drug monitoring of cannabidiol in patients with refractory epilepsy. Epilepsia. 66(5). 1477–1491. 4 indexed citations
3.
Heuser, Kjell, Jugoslav Ivanović, Arild Egge, et al.. (2024). A case of acute functional hemispherotomy in a young woman with hemimegalencephaly and super-refractory status epilepticus. Epilepsy & Behavior Reports. 28. 100728–100728.
4.
Nakken, Karl O. & Erik Sætre. (2020). Anfallsforebyggende legemidler, ikke antiepileptika. Tidsskrift for Den norske legeforening. 1 indexed citations
5.
Lund, Caroline, Margrete Larsen Burns, Marit Bjørnvold, et al.. (2020). A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway. Epilepsia Open. 5(3). 432–441. 21 indexed citations
6.
Landmark, Cecilie Johannessen, Caroline Lund, Margrete Larsen Burns, et al.. (2020). Pharmacokinetic Variability During Long-Term Therapeutic Drug Monitoring of Valproate, Clobazam, and Levetiracetam in Patients With Dravet Syndrome. Therapeutic Drug Monitoring. 42(5). 744–753. 12 indexed citations
7.
Sætre, Erik & Michael Abdelnoor. (2018). Incidence rate of sudden death in epilepsy: A systematic review and meta-analysis. Epilepsy & Behavior. 86. 193–199. 29 indexed citations
8.
Baftiu, Arton, Pål G. Larsson, Margrete Larsen Burns, et al.. (2017). Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway, 2004-2015. Epilepsy Research. 139. 35–42. 28 indexed citations
9.
Svendsen, Torleiv, Eylert Brodtkorb, Arne Reimers, et al.. (2016). Pharmacokinetic variability, efficacy and tolerability of eslicarbazepine acetate–A national approach to the evaluation of therapeutic drug monitoring data and clinical outcome. Epilepsy Research. 129. 125–131. 15 indexed citations
10.
Nakken, Karl O., et al.. (2013). Epilepsi hos eldre. Tidsskrift for Den norske legeforening. 133(5). 528–531. 2 indexed citations
11.
Sætre, Erik, Michael Abdelnoor, Emilio Perucca, et al.. (2010). Antiepileptic drugs and quality of life in the elderly: Results from a randomized double-blind trial of carbamazepine and lamotrigine in patients with onset of epilepsy in old age. Epilepsy & Behavior. 17(3). 395–401. 18 indexed citations
12.
Sætre, Erik, Jan Amlie, Emilio Perucca, et al.. (2009). Cardiac function and antiepileptic drug treatment in the elderly: A comparison between lamotrigine and sustained‐release carbamazepine. Epilepsia. 50(8). 1841–1849. 45 indexed citations
14.
Leppik, Ilo E., Martin J. Brodie, Erik Sætre, et al.. (2006). Outcomes research: Clinical trials in the elderly. Epilepsy Research. 68. 71–76. 27 indexed citations
15.
Svalheim, Sigrid, Erik Taubøll, Line Sveberg Røste, et al.. (2006). Onset of epilepsy and menarche—Is there any relationship?. Seizure. 15(8). 571–575. 9 indexed citations
16.
Røste, Line Sveberg, Erik Taubøll, Lars Mørkrid, et al.. (2005). Antiepileptic drugs alter reproductive endocrine hormones in men with epilepsy. European Journal of Neurology. 12(2). 118–124. 69 indexed citations
17.
Røste, Line Sveberg, et al.. (2003). Alterations in semen parameters in men with epilepsy treated with valproate or carbamazepine monotherapy. European Journal of Neurology. 10(5). 501–506. 59 indexed citations
18.
Svalheim, Sigrid, Erik Taubøll, Line Sveberg Røste, et al.. (2003). Do women with epilepsy have increased frequency of menstrual disturbances?. Seizure. 12(8). 529–533. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026